Drugs / MNI-513
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01000870 | Oct 2009 → Sep 2010 | Alzheimer disease | Institute for Neurodegenerative Disorders | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNI-513 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01000870 ↗ |
| Modality | Diagnostic / imaging agent | “MNI-513 positron emission tomography (PET)” NCT01000870 ↗ |
| Route | Intravenous | “single IV injection” NCT01000870 ↗ |